Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1984 May 1;130(9):1169-71, 1174.

Rebound of vasospastic angina after cessation of long-term treatment with nifedipine.

J Lette, R M Gagnon, J G Lemire, M Morissette
PMCID: PMC1876004  PMID: 6713338

Abstract

The beneficial effect of calcium antagonists in the treatment of vasospastic angina is now well recognized. Although withdrawal symptoms have been reported following abrupt cessation of therapy with some cardiovascular drugs, there is no detailed report on similar complications of the cessation of therapy with calcium antagonists. In a 4-month period eight patients with well documented and well controlled vasospastic angina experienced a marked increase in the frequency and duration of anginal episodes at rest following the involuntary cessation of treatment with nifedipine, 10 to 20 mg four times a day. The increase began within 2 to 5 days after the cessation of treatment. Substitute therapy with isosorbide dinitrate, 30 mg, and verapamil, 80 to 120 mg, each four times a day, was effective in all cases. Although the mechanism responsible for this rebound phenomenon is not known, awareness of its existence is essential considering the widespread use of calcium antagonists.

Full text

PDF
1169

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Emanuel M. B. Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology. 1979 Jul;30(7):454–469. doi: 10.1177/000331977903000704. [DOI] [PubMed] [Google Scholar]
  2. Freedman S. B., Richmond D. R., Kelly D. T. Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. Am J Cardiol. 1982 Oct;50(4):711–715. doi: 10.1016/0002-9149(82)91223-1. [DOI] [PubMed] [Google Scholar]
  3. Hansson L., Hunyor S. N., Julius S., Hoobler S. W. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J. 1973 May;85(5):605–610. doi: 10.1016/0002-8703(73)90165-8. [DOI] [PubMed] [Google Scholar]
  4. Heupler F. A., Jr, Proudfit W. L. Nifedipine therapy for refractory coronary arterial spasm. Am J Cardiol. 1979 Oct 22;44(5):798–803. doi: 10.1016/0002-9149(79)90200-5. [DOI] [PubMed] [Google Scholar]
  5. Hillis L. D., Braunwald E. Coronary-artery spasm. N Engl J Med. 1978 Sep 28;299(13):695–702. doi: 10.1056/NEJM197809282991305. [DOI] [PubMed] [Google Scholar]
  6. Hugenholtz P. G., Michels H. R., Serruys P. W., Brower R. W. Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia. Am J Cardiol. 1981 Jan;47(1):163–173. doi: 10.1016/0002-9149(81)90305-2. [DOI] [PubMed] [Google Scholar]
  7. Lange R. L., Reid M. S., Tresch D. D., Keelan M. H., Bernhard V. M., Coolidge G. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation. 1972 Oct;46(4):666–678. doi: 10.1161/01.cir.46.4.666. [DOI] [PubMed] [Google Scholar]
  8. MacAlpin R. N., Kattus A. A., Alvaro A. B. Angina pectoris at rest with preservation of exercise capacity: Prinzmetal's variant angina. Circulation. 1973 May;47(5):946–958. doi: 10.1161/01.cir.47.5.946. [DOI] [PubMed] [Google Scholar]
  9. Maseri A., L'Abbate A., Baroldi G., Chierchia S., Marzilli M., Ballestra A. M., Severi S., Parodi O., Biagini A., Distante A. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978 Dec 7;299(23):1271–1277. doi: 10.1056/NEJM197812072992303. [DOI] [PubMed] [Google Scholar]
  10. Maseri A., Severi S., Nes M. D., L'Abbate A., Chierchia S., Marzilli M., Ballestra A. M., Parodi O., Biagini A., Distante A. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978 Dec;42(6):1019–1035. doi: 10.1016/0002-9149(78)90691-4. [DOI] [PubMed] [Google Scholar]
  11. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  12. Neill W. A., Wharton T. P., Jr, Fluri-Lundeen J., Cohen I. S. Acute coronary insufficiency - coronary occlusion after intermittent ischemic attacks. N Engl J Med. 1980 May 22;302(21):1157–1162. doi: 10.1056/NEJM198005223022101. [DOI] [PubMed] [Google Scholar]
  13. Olivari M. T., Bartorelli C., Polese A., Fiorentini C., Moruzzi P., Guazzi M. D. Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation. 1979 May;59(5):1056–1062. doi: 10.1161/01.cir.59.5.1056. [DOI] [PubMed] [Google Scholar]
  14. Polese A., Fiorentini C., Olivari M. T., Guazzi M. D. Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med. 1979 May;66(5):825–830. doi: 10.1016/0002-9343(79)91123-9. [DOI] [PubMed] [Google Scholar]
  15. Simonneau G., Escourrou P., Duroux P., Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med. 1981 Jun 25;304(26):1582–1585. doi: 10.1056/NEJM198106253042606. [DOI] [PubMed] [Google Scholar]
  16. Stone P. H., Antman E. M., Muller J. E., Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med. 1980 Dec;93(6):886–904. doi: 10.7326/0003-4819-93-6-886. [DOI] [PubMed] [Google Scholar]
  17. Subramanian V. B., Bowles M. J., Khurmi N. S., Davies A. B., O'Hara M. J., Raftery E. B. Calcium antagonist withdrawal syndrome: objective demonstration with frequency-modulated ambulatory ST-segment monitoring. Br Med J (Clin Res Ed) 1983 Feb 12;286(6364):520–521. doi: 10.1136/bmj.286.6364.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Waters D. D., Szlachcic J., Theroux P., Dauwe F., Mizgala H. F. Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugs. Am J Cardiol. 1981 Jan;47(1):179–184. doi: 10.1016/0002-9149(81)90307-6. [DOI] [PubMed] [Google Scholar]
  19. Waters D. D., Théroux P., Szlachcic J., Dauwe F. Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina. Am J Cardiol. 1981 Jul;48(1):123–130. doi: 10.1016/0002-9149(81)90581-6. [DOI] [PubMed] [Google Scholar]
  20. Whiting R. B., Klein M. D., Vander Veer J., Lown B. Variant angina pectoris. N Engl J Med. 1970 Mar 26;282(13):709–712. doi: 10.1056/NEJM197003262821303. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES